Compounds > u 73343
Page last updated: 2024-09-02

u 73343 and 6-cyano-7-nitroquinoxaline-2,3-dione

u 73343 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies

Compound Research Comparison

Studies
(u 73343)		Trials
(u 73343)		Recent Studies (post-2010)
(u 73343)		Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)		Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)		Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
97062,6981353

Protein Interaction Comparison

ProteinTaxonomyu 73343 (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, T; Ishii, T; Ohmori, H1
Aroniadou-Anderjaska, V; Braga, MF; Hough, CJ; Li, H; Manion, ST1

Other Studies

2 other study(ies) available for u 73343 and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Release of Ca2+ is the crucial step for the potentiation of IPSCs in the cultured cerebellar Purkinje cells of the rat.
    The Journal of physiology, 1996, Dec-15, Volume: 497 ( Pt 3)

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Calcium Channels; Chelating Agents; Cycloleucine; Egtazic Acid; Enzyme Inhibitors; Estrenes; Evoked Potentials; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Heparin; Neuroprotective Agents; Phosphodiesterase Inhibitors; Purkinje Cells; Pyrrolidinones; Rats; Receptors, Metabotropic Glutamate; Ruthenium Red; Synapses; Thapsigargin; Type C Phospholipases

1996
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aging; Amygdala; Anesthetics, Local; Animals; Animals, Newborn; Bicuculline; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Estrenes; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Imidazoles; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Morpholines; Neural Inhibition; Neurons; Norepinephrine; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Restraint, Physical; Stress, Physiological; Tetrahydronaphthalenes; Tetrodotoxin; Time Factors

2004